Broad Antitumor Activity in Breast Cancer Xenografts by Motesanib, a Highly Selective, Oral Inhibitor of Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors

2008 ◽  
Vol 15 (1) ◽  
pp. 110-118 ◽  
Author(s):  
Angela Coxon ◽  
Tammy Bush ◽  
Douglas Saffran ◽  
Stephen Kaufman ◽  
Brian Belmontes ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document